Breaking AI & Tech News Analyzed

Doctors Without Borders (MSF) has condemned a drone strike that hit Al Jabalain Hospital in Sudan’s White Nile State, killing 10 people, among them seven medical staff members. The attack, which struck an operating theatre and a maternity ward, occurred during a children’s immunisation campaign, heightening the humanitarian outcry.MSF’s Sudan emergencies chief, Esperanza Santos, said the assault was “unacceptable” and noted that several of the deceased had previously worked with the organisation. She added that the strike represents a grave violation of medical neutrality.While the perpetrators have not been officially confirmed, MSF’s statement attributes the strike to the paramilitary Rapid Support Forces (RSF), a claim echoed by Sudanese officials. On Friday, Khalid Aleisir, Sudan’s minister of culture, information, antiquities and tourism, called for the RSF to be designated a terrorist organisation and for its members to face prosecution.The incident follows a series of attacks on Sudan’s health infrastructure since the war erupted in April 2023. In a separate incident the same day, a medical supply depot in Rabak, the capital of White Nile State, was also hit. According to the World Health Organization, more than 200 attacks have targeted health facilities since the conflict began, underscoring a systematic pattern of violence against civilians.Local rights group Emergency Lawyers highlighted that recurring drone strikes across South Kordofan, Blue Nile, and the Darfur regions have displaced thousands, further straining an already fragile health system. The Sudan Doctors Network described the Al Jabalain strike as a “deliberate assault on health facilities and unarmed civilians,” warning that such actions exacerbate the nation’s deteriorating medical capacity.International observers note that the targeting of hospitals not only violates international humanitarian law but also hampers efforts to control disease outbreaks and provide essential care to vulnerable populations. The growing body of evidence may prompt renewed calls for accountability and stronger protective measures for health workers in conflict zones.

The World Health Organisation (WHO) has issued a stern warning against the ongoing US-Israeli attacks on Iranian healthcare facilities, amid the escalating conflict. The organisation's chief, Tedros Adhanom Ghebreyesus, reported that over 20 attacks on healthcare facilities in Iran have been verified since March 1, resulting in at least nine deaths, including an infectious diseases health worker and a member of the Iranian Red Crescent Society.The Pasteur Institute in Tehran, one of the oldest research and health facilities in the country, has sustained significant damage and was rendered unable to continue delivering health services. Iranian Ministry of Health spokesperson Hossein Kermanpour shared images of the heavily damaged building on social media, with parts of the facility reduced to rubble.Despite the attacks, Iran's ISNA news agency reported that the services of the Pasteur Institute have not been interrupted, and vaccine and serum production would continue. The WHO chief emphasised that the Institute plays a crucial role in protecting and promoting population health, particularly in emergencies.The attacks have not been limited to the Pasteur Institute. The WHO has reported damage to other healthcare facilities, including the Delaram Sina Psychiatric Hospital and the Tofigh Daru pharmaceutical facility, with no casualties reported. An explosion near the Imam Ali Hospital in Khuzestan province led to the facility's evacuation and cessation of services.Tedros stressed that humanitarian workers, ambulances, relief supplies, and humanitarian facilities must be respected and protected under international law. The Geneva Conventions, agreed upon after World War II, designate healthcare facilities as protected locations.The Iranian Red Crescent Society reported that a warehouse belonging to the organisation was targeted, destroying two-wheeled relief containers and two buses and relief vehicles. According to the organisation, 307 health, medical, and emergency care facilities have been damaged in the war.

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

The UK medicines regulator has opened an inquiry into a growing number of clinics that sell injectable peptides while promoting them as cures for everything from ageing to injury recovery. The investigation, disclosed by the Guardian, focuses on whether these businesses are breaching the Human Medicines Regulations 2012 by making unauthorised medicinal claims. Interest in peptide‑based treatments has surged in recent years, driven by social‑media influencers, some healthcare professionals, and direct‑to‑consumer marketers. Yet the scientific foundation for most of these claims is weak, with the bulk of research confined to animal models or cell‑culture studies. According to an MHRA spokesperson, any clinic that advertises a peptide as having therapeutic benefits must treat the product as a medicine, which triggers a comprehensive regulatory framework. "If clinics offering peptide injections make medicinal claims for those treatments, the products will be considered medicines and subject to regulation," the agency warned, adding that it will act against any identified breaches. Guardian reporters identified several high‑ranking Google search results that list peptides such as Cortexin (promoted for neuroprotection), BPC‑157 (claimed to aid tissue repair), and Thymosin Alpha (advertised to boost immunity). After being contacted, one clinic removed the statements from its website. Another clinic, while acknowledging the limited human evidence, continued to market seven specific peptides, providing price lists (£350 per month for a single peptide, £450 for two) and offering delivery via vials, syringes, or pre‑filled pens for an additional fee. During a free consultation, a clinician highlighted the experimental nature of the products, noting the absence of large‑scale, randomised clinical trials and recommending a break of four to eight weeks between treatment cycles to mitigate unknown risks. The clinician suggested BPC‑157 for post‑exercise recovery, describing it as a facilitator of cellular repair and blood flow, but warned against its use in smokers or individuals with a family history of cancer due to potential angiogenic effects. The second peptide discussed was MOTS‑C, portrayed as a mitochondrial enhancer that could improve stress resilience, lower insulin resistance, and reduce visceral fat by boosting cellular energy production (ATP). The MHRA confirmed it is reviewing whether the clinician’s statements constitute medicinal claims. The clinic defended its approach, emphasizing that it clearly informs clients that the peptides are not licensed medicines and that the evidence base is largely pre‑clinical. In a broader statement, Lynda Scammell, head of borderline products at the MHRA, explained that peptide products may be marketed as cosmetics, supplements, or medicines, and each case is assessed on its intended use, pharmacological effect, and supporting evidence. She added, "We disregard claims that products are for ‘research purposes’ if it is clear that such claims are being used as an attempt to avoid medicines regulations." Peptides are short chains of amino acids, some of which occur naturally (e.g., insulin). While synthetic peptide analogues like semaglutide and tirzepatide have secured approval for weight‑loss treatments, many of the compounds promoted by these clinics remain experimental and lack the rigorous safety and efficacy testing required for medicinal products.

When the sanctioned Russian tanker Anatoly Kolodkin docked at Matanzas and off‑loaded roughly 700,000 barrels of crude, observers were left questioning why Washington had temporarily lifted its oil embargo on the island.Just weeks earlier, President Donald Trump had taken to social media to declare an end to any oil or cash flowing to Cuba. Yet, in a stark reversal, he later told reporters he had no objection to oil shipments reaching the country, allowing the Russian vessel to pass.Adding to the intrigue, Cuban authorities announced the release of 2,010 prisoners as a “humanitarian gesture” for Holy Week. Analysts quickly linked the pardons to the tanker’s arrival, interpreting both moves as evidence of ongoing, albeit secret, talks between Washington and Havana.The U.S. oil blockade has already pushed Cuba’s fragile economy to the brink: tourism has all but vanished after airlines from Canada, Russia, China and France withdrew, with Iberia set to exit by the end of May. Most petrol stations are shuttered and blackouts have become a daily reality.Population estimates now sit at 9.5 million, down from a pre‑crisis peak after a two‑million‑person exodus over the past five years. Citizens describe a systemic collapse of health, education and transport services.With official channels silent, Cubans are piecing together fragmented leaks—largely from the U.S. side—to gauge the direction of the negotiations.The dialogue pits Trump’s hard‑line rhetoric, which vows to “take” the island, against Cuba’s insistence that its political system is non‑negotiable.One diplomat suggested the tanker’s arrival could be a tactical humanitarian showcase, but also noted it might serve as a confidence‑building measure. The simultaneous prisoner release leans toward the latter interpretation.Professor William LeoGrande of American University observed that such reciprocal gestures often precede substantive diplomatic progress.Meanwhile, another Russian‑flagged tanker, the Sea Horse, carrying about 200,000 barrels, was sighted moving toward Venezuela, hinting at a coordinated “carrot” strategy aimed at both Havana and Caracas.Although oil alone is unlikely to compel the Cuban regime to relinquish power, the recent events suggest a more transactional pathway may be emerging.Since 2021, Cuba has nurtured a private sector of over 10,000 small‑ and medium‑sized enterprises (Mipymes), spawning a new class of affluent Cubans often tied to the regime and the army’s economic arm, Gaesa.Negotiations appear to be led by Raúl Guillermo Rodríguez Castro, a grandson of former President Raúl Castro and son of the late Gaesa chief Luis Rodríguez López‑Calleja.In a recent CNN interview, Fidel Castro’s grandson Sandro Castro, a 33‑year‑old influencer and businessman, argued that the majority of Cubans now favor a capitalist model over communism.His open criticism of President Miguel Díaz‑Canel—calling his performance “unsatisfactory”—would normally trigger state security action, yet appears tolerated, suggesting the U.S. may be leveraging Díaz‑Canel’s vulnerability in the talks.Analysts speculate a possible outcome where Cuba’s economy opens to foreign investment while senior Castros retain political influence, aligning with Trump’s expressed desire for a “friendly” transition reminiscent of recent moves in Venezuela.One senior diplomat in Havana noted that the United States might permit existing private businesses to continue operating, provided they also open markets to U.S. interests.The prospect of any Castro family member retaining authority is likely to provoke fierce opposition from hard‑line Cuban‑American groups, epitomized by figures like Marco Rubio, who have long advocated for the Castros’ removal.Perhaps the greatest concern remains the roughly 40 % of Cubans who are not part of the private sector and rely on state support; many are elderly and now face the very real threat of starvation.

A devastating incident unfolded at the Alejandro Villanueva Stadium in Lima, Peru, on Friday, claiming the life of one person and injuring dozens more. The event, which was a 'flag-waving' gathering, took place a day before a highly anticipated derby match between Alianza Lima and Universitario de Deportes.The Peruvian health minister, Juan Carlos Velasco Guerrero, confirmed the death and reported that 47 people were injured, with three in critical condition. Initial reports suggested that parts of the stadium's wall had collapsed, but officials later clarified that there were no structural failures.Alianza Lima expressed condolences for the casualties and pledged to cooperate fully with authorities to investigate the incident. The club promised 'total transparency' in the investigation.The Peruvian professional soccer league announced that Saturday's match would proceed as planned, emphasizing its commitment to ensuring safe environments for spectators. The league will continue to work closely with clubs and authorities to promote safety and wellbeing at sporting events.The Alejandro Villanueva Stadium, also known as Matute, was built in the 1970s and has a capacity of over 33,900 seats. Despite limited modernization, the stadium remains a 'fairly basic ground,' according to The Stadium Guide.

More than 100 United States‑based international law scholars have signed an open letter denouncing the recent US‑Israeli strikes on Iran as a violation of the United Nations Charter and potentially amounting to war crimes. The letter, released on Thursday, asserts that the campaign – launched on February 28 – proceeded without UN Security Council authorization and without credible evidence of an imminent Iranian threat. According to the scholars, the legal basis for force against another state exists only in self‑defence against an actual or imminent armed attack, or when expressly sanctioned by the Security Council. Iran has not attacked the United States or Israel, and the Security Council did not approve the operation. The experts organize their concerns into four categories: the legality of the war decision, the conduct of hostilities, threatening rhetoric from senior officials, and what they describe as the dismantling of civilian‑protection safeguards within the US defence establishment under Secretary of Defense Pete Hegseth’s “gloves‑off” approach. Among the most alarming incidents highlighted is the strike on a primary school in Minab, Iran on the first day of the conflict, which killed at least 175 people, the majority of them children. The letter also cites attacks on hospitals, water treatment facilities, and energy infrastructure, emphasizing that schools, health facilities, and homes have been targeted. The signatories condemn public statements by senior US officials, including a mid‑March remark by former President Donald Trump that the United States might strike Iran “just for fun,” and early‑March comments from Pentagon chief Pete Hegseth dismissing “stupid rules of engagement.” They argue that such rhetoric reflects an “alarming disrespect” for international humanitarian law, which is designed to protect civilians and combatants alike. Financially, the letter notes that the war is costing US taxpayers up to $2 billion per day, underscoring the broader economic burden of the conflict. The open letter was co‑authored by prominent legal scholars such as Yale Law School’s Oona Hathaway, former State Department legal adviser Harold Koh, NYU’s Philip Alston, and former Human Rights Watch chief Kenneth Roth. While the authors focus on the United States’ conduct, they warn of a heightened risk of atrocities throughout the region. Emphasizing the need for consistent application of international law, the scholars write: “We urge US government officials to uphold the UN Charter, international humanitarian law, and human rights law at all times, and to publicly make clear US commitment to and respect for norms of international law.”

President Donald Trump has unveiled a bold budget request, seeking $1.5 trillion for military spending, a nearly 40% increase from the previous year. This ambitious proposal underscores the White House's priorities, emphasizing military strength and law enforcement.The budget request, while not legally binding, sets the stage for intense congressional negotiations. It includes a proposed $455 billion increase over fiscal year 2026, separate from an emergency request of $200 billion for the US-Israeli conflict with Iran.The plan involves significant shifts in funding, with $73 billion in cuts to domestic programs, including initiatives to counter climate change, boost renewable energy, and support equality and access in housing, education, and healthcare. Instead, funding would be redirected to projects such as Trump's Golden Dome missile defense system, critical minerals investment, US shipbuilding, and troop salary increases.Trump's proposal also emphasizes immigration enforcement, calling for continued funding for the Department of Homeland Security and Immigration and Customs Enforcement to support his mass deportation campaign. The request includes a 13% increase for the Department of Justice, focusing on violent crime.The budget plan faces challenges, including a potential deadlock in Congress over funding for ICE and Customs and Border Patrol. The administration suggests passing the budget through a mechanism known as reconciliation, which could be achieved with a simple majority in Congress.The US military expenditure has steadily increased, reaching $997 billion in 2024, according to the Stockholm International Peace Research Institute. The country consistently spends more on its military than the next nine countries combined, raising questions about priorities in defense and domestic spending.

The conflict between the US and Israel against Iran has taken a devastating toll on the country's healthcare system. At least 2,076 people have been killed and 26,500 wounded in Iran since the US and Israel first launched strikes on the country on February 28.Iranian President Masoud Pezeshkian has strongly condemned the attacks, appealing to international health organizations to respond to the crisis. On Thursday, he wrote on X: “What message does attacking hospitals, pharmaceutical companies and the Pasteur Institute as a medical research center in Iran convey?”The Pasteur Institute, a key center for medical research and vaccine production in Tehran, has been targeted. The institute, founded over 100 years ago in collaboration with the Institut Pasteur in Paris, conducts research on infectious diseases, produces vaccines, and provides advanced diagnostics.According to the World Health Organization (WHO), over 20 attacks on healthcare facilities in Iran have been verified since March 1, resulting in at least nine deaths, including an infectious diseases health worker and a member of the Iranian Red Crescent Society.Some of the facilities hit include:Red Crescent warehouse in Bushehr province, which was destroyed by a drone strike on Friday morning.Tofigh Daru Research and Engineering Company, one of Iran’s largest pharmaceutical companies, which was hit on March 31.Delaram Sina Psychiatric Hospital in Tehran, which was significantly damaged on March 29.Ali Hospital in Andimeshk, which sustained damage from an explosion on March 21.Gandhi Hospital in Tehran, which was damaged during attacks on a nearby television communications tower on March 2.International humanitarian law states that health establishments and units, including hospitals, should not be attacked. The United Nations Security Council resolution 2286 was adopted unanimously in 2016, condemning attacks on healthcare and calling on nations to respect international law.The attacks on healthcare facilities are not limited to Iran. Israel has also targeted healthcare facilities in Lebanon and Gaza, resulting in significant damage and loss of life.